Post-acute care is an increasingly important part of the healthcare journey. Yet for health plans, health systems, providers, and the clinicians supporting patients through these transitions, the information needed to make timely, informed decisions often remains fragmented across settings and systems.
At Post Acute Analytics, we believe there is a better way.
Our latest round of financing, which included participation from Humana and another strategic investor alongside existing investors Warburg Pincus, Dorilton Capital, and Generator Ventures, represents more than an investment in PAA. It reflects continued confidence in the opportunity to transform how healthcare organizations understand, navigate, and manage post-acute care.
Accelerating Anna® Clinical Intelligence
At the center of that vision is Anna®, PAA's Clinical Intelligence Engine.
Anna transforms fragmented clinical data into actionable intelligence, helping care teams understand what is happening with a patient, identify what matters, and make more informed decisions at critical points in the care journey.
This investment enables PAA to accelerate the continued development of Anna® and expand the capabilities available to our health plan, health system, and provider partners.
It also allows us to continue building a more connected post-acute ecosystem, where Clinical Intelligence can support decision-making from the initial transition out of the hospital through skilled nursing, home health, and beyond.
Building the Future With Strategic Partners
The participation of strategic healthcare investors is particularly meaningful.
Transforming post-acute care cannot happen through technology alone. It requires collaboration among the organizations responsible for financing care, delivering care, managing transitions, and supporting patients throughout their recovery.
These partnerships create an opportunity to build solutions around real clinical and operational challenges, validate them in complex healthcare environments, and bring those solutions to scale.
As PAA CEO Saqib Akhter shared when the financing was announced, the investment reflects the real-world impact of empowering care teams with timely insights, supporting safer transitions, and creating measurable value across the continuum.
For PAA, this next chapter is about accelerating that work.
We are continuing to build toward a future where clinicians have the right information, in the right context, at the right moment to make smarter care decisions.
About the Author
Lynn Mueller
SVP, Growth
Lynn Mueller is Senior Vice President of Growth at Post Acute Analytics, where she leads strategic growth and partnerships with health plans. With deep experience in healthcare strategy and business development, she focuses on building partnerships that help organizations modernize post-acute care, reduce administrative complexity, and improve care delivery through clinical intelligence.
Connect on LinkedIn (opens in a new tab)